EUVIMEDEUVIMED entdecken
Crossref

Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects

Denise N Keller, Samantha J Medwid, Cameron D Ross, Theodore J Wigle, Richard B Kim

Pharmacogenetics and Genomics · 2023-01 · 33 (1) · 10-18

DOI: 10.1097/fpc.0000000000000486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacogenetics and Genomics, online erschienen am 07.11.2022. Verfasst von Denise N Keller und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy services, London Health Sciences Centre. Hauptthemen laut MEDLINE: Breast Neoplasms, Organic Anion Transporters, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Drug transporters are important determinants of drug disposition and response. Tamoxifen is an antiestrogen for breast cancer therapy known for adverse drug reactions (ADRs). In this study, the involvement of OATP transporters in tamoxifen and endoxifen transport was studied in vitro while the impact of single nucleotide variation (SNV) in OATP and efflux transporters P-glycoprotein ( ABCB1 ) and Breast Cancer Resistance Protein ( ABCG2 ) on ADRs during tamoxifen therapy were assessed.

Methods

Patients receiving tamoxifen for breast cancer, who were CYP2D6 normal metabolizers were enrolled ( n = 296). Patients completed a survey that captured ADRs and a blood sample was collected. Tamoxifen and endoxifen plasma concentration were measured, while DNA was genotyped for SNVs in ABCB1, ABCG2, SLCO1A2, SLCO1B1 , and SLCO2B1 . HEK293T cells were used to determine the extent of OATP-mediated transport of tamoxifen and endoxifen.

Results

Common SNVs of ABCB1, ABCG2, SLCO1A2 , and SLCO1B1 were not associated with tamoxifen or endoxifen concentration. However, tamoxifen concentration was significantly higher in carriers of SLCO2B1 c.935G>A (129.8 ng/mL) compared to wildtype (114.9 ng/mL; P = 0.036). Interestingly, subjects who carried SLCO1A2 c.38A>G reported significantly less dizziness ( P = 0.016). In-vitro analysis demonstrated increased cellular accumulation of tamoxifen in cells overexpressing OATP1A2 and 1B1, but endoxifen uptake was not effected in OATP overexpressing cells.

Conclusions

We showed that OATP1A2 , a transporter known to be expressed at the blood-brain barrier, is capable of tamoxifen transport. Additionally, OATP1A2 c.38A>G was associated with reduced ADRs. Taken together, our findings suggest genetic variation in OATP transporters may be an important predictor of tamoxifen ADRs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsOrganic Anion TransportersDrug-Related Side Effects and Adverse ReactionsHumansFemaleATP Binding Cassette Transporter, Subfamily B, Member 1ATP Binding Cassette Transporter, Subfamily G, Member 2HEK293 CellsNeoplasm ProteinsTamoxifenATP Binding Cassette Transporter, Subfamily BLiver-Specific Organic Anion Transporter 1

Substanzen

4-hydroxy-N-desmethyltamoxifenATP Binding Cassette Transporter, Subfamily B, Member 1ATP Binding Cassette Transporter, Subfamily G, Member 2Neoplasm ProteinsTamoxifenATP Binding Cassette Transporter, Subfamily BOrganic Anion TransportersSLCO1B1 protein, humanLiver-Specific Organic Anion Transporter 1

Autor:innen und Institutionen

  • Pharmacy services, London Health Sciences Centre.
  • Department of Medicine, University of Western Ontario, Canada.

Förderung

  • CIHR

Zitieren

APA

Keller, D. N., Medwid, S. J., Ross, C. D., Wigle, T. J., & Kim, R. B. (2023). Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects. Pharmacogenetics and Genomics, 33(1), 10-18. https://doi.org/10.1097/fpc.0000000000000486

Vancouver

Keller DN, Medwid SJ, Ross CD, Wigle TJ, Kim RB. Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects. Pharmacogenetics and Genomics. 2023;33(1):10-18. doi:10.1097/fpc.0000000000000486

BibTeX
@article{Keller2023,
  author = {Keller, Denise N and Medwid, Samantha J and Ross, Cameron D and Wigle, Theodore J and Kim, Richard B},
  title = {Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects},
  journal = {Pharmacogenetics and Genomics},
  year = {2023},
  volume = {33},
  number = {1},
  pages = {10--18},
  doi = {10.1097/fpc.0000000000000486}
}
Kostenlos starten →